DNMT1: A Key Drug Target in Triple-Negative Breast Cancer

Title
DNMT1: A Key Drug Target in Triple-Negative Breast Cancer
Authors
Keywords
DNMT1, Methylation, Triple-negative breast cancer, Epithelial-mesenchymal transition, Inhibitors
Journal
SEMINARS IN CANCER BIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-05-24
DOI
10.1016/j.semcancer.2020.05.010

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search